BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 22287060)

  • 1. Hypoxia upregulates ovarian cancer invasiveness via the binding of HIF-1α to a hypoxia-induced, methylation-free hypoxia response element of S100A4 gene.
    Horiuchi A; Hayashi T; Kikuchi N; Hayashi A; Fuseya C; Shiozawa T; Konishi I
    Int J Cancer; 2012 Oct; 131(8):1755-67. PubMed ID: 22287060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypomethylation-induced expression of S100A4 in endometrial carcinoma.
    Xie R; Loose DS; Shipley GL; Xie S; Bassett RL; Broaddus RR
    Mod Pathol; 2007 Oct; 20(10):1045-54. PubMed ID: 17673926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Over-expression of hypoxia-inducible factor 1 alpha in ovarian clear cell carcinoma.
    Lee S; Garner EI; Welch WR; Berkowitz RS; Mok SC
    Gynecol Oncol; 2007 Aug; 106(2):311-7. PubMed ID: 17532031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of salusin-β is associated with poor prognosis in ovarian cancer.
    Zhang Q; Chen WM; Zhang XX; Zhang HX; Wang HC; Zheng FY; Zhu FF
    Oncol Rep; 2017 Mar; 37(3):1826-1832. PubMed ID: 28184918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential transcriptional and protein expression of thyroid-stimulating hormone receptor in ovarian carcinomas.
    Gyftaki R; Liacos C; Politi E; Liontos M; Saltiki K; Papageorgiou T; Thomakos N; Haidopoulos D; Rodolakis A; Alevizaki M; Bamias A; Dimopoulos A
    Int J Gynecol Cancer; 2014 Jun; 24(5):851-6. PubMed ID: 24844218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EZH2 supports ovarian carcinoma cell invasion and/or metastasis via regulation of TGF-beta1 and is a predictor of outcome in ovarian carcinoma patients.
    Rao ZY; Cai MY; Yang GF; He LR; Mai SJ; Hua WF; Liao YJ; Deng HX; Chen YC; Guan XY; Zeng YX; Kung HF; Xie D
    Carcinogenesis; 2010 Sep; 31(9):1576-83. PubMed ID: 20668008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic and genetic alterations of p33ING1b in ovarian cancer.
    Shen DH; Chan KY; Khoo US; Ngan HY; Xue WC; Chiu PM; Ip P; Cheung AN
    Carcinogenesis; 2005 Apr; 26(4):855-63. PubMed ID: 15677627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of S100A4 expression via the JAK2-STAT3 pathway in rhomboid-phenotype pulmonary arterial smooth muscle cells exposure to hypoxia.
    Liu T; Li Y; Lin K; Yin H; He B; Zheng M; Wang G
    Int J Biochem Cell Biol; 2012 Aug; 44(8):1337-45. PubMed ID: 22561747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wilms tumor gene protein 1 is associated with ovarian cancer metastasis and modulates cell invasion.
    Barbolina MV; Adley BP; Shea LD; Stack MS
    Cancer; 2008 Apr; 112(7):1632-41. PubMed ID: 18260155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of protease activated receptor 1 (Par1) and pY397FAK in benign and malignant human ovarian tissue samples.
    Grisaru-Granovsky S; Salah Z; Maoz M; Pruss D; Beller U; Bar-Shavit R
    Int J Cancer; 2005 Jan; 113(3):372-8. PubMed ID: 15455382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sterol regulatory element-binding protein 1 is required for ovarian tumor growth.
    Nie LY; Lu QT; Li WH; Yang N; Dongol S; Zhang X; Jiang J
    Oncol Rep; 2013 Sep; 30(3):1346-54. PubMed ID: 23818099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Musashi-2 is a novel regulator of paclitaxel sensitivity in ovarian cancer cells.
    Lee J; An S; Choi YM; Lee J; Ahn KJ; Lee JH; Kim TJ; An IS; Bae S
    Int J Oncol; 2016 Nov; 49(5):1945-1952. PubMed ID: 27600258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of hypoxia-inducible factor 1alpha, hypoxia-inducible factor 2alpha, and von Hippel-Lindau protein in epithelial ovarian neoplasms and allelic loss of von Hippel-Lindau gene: nuclear expression of hypoxia-inducible factor 1alpha is an independent prognostic factor in ovarian carcinoma.
    Osada R; Horiuchi A; Kikuchi N; Yoshida J; Hayashi A; Ota M; Katsuyama Y; Melillo G; Konishi I
    Hum Pathol; 2007 Sep; 38(9):1310-20. PubMed ID: 17555795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypomethylation-induced expression of S100A4 increases the invasiveness of laryngeal squamous cell carcinoma.
    Liu J; Guo Y; Fu S; Yang M; Sun KL; Fu WN
    Oncol Rep; 2010 Apr; 23(4):1101-7. PubMed ID: 20204297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of hypoxia inducible factors on the immune microenvironment in ovarian cancer.
    Duechler M; Peczek L; Szubert M; Suzin J
    Anticancer Res; 2014 Jun; 34(6):2811-9. PubMed ID: 24922644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Snail, Slug, and Smad-interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma.
    Elloul S; Elstrand MB; Nesland JM; Tropé CG; Kvalheim G; Goldberg I; Reich R; Davidson B
    Cancer; 2005 Apr; 103(8):1631-43. PubMed ID: 15742334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p70 S6 kinase promotes epithelial to mesenchymal transition through snail induction in ovarian cancer cells.
    Pon YL; Zhou HY; Cheung AN; Ngan HY; Wong AS
    Cancer Res; 2008 Aug; 68(16):6524-32. PubMed ID: 18701475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of galectin-7 in epithelial ovarian cancer.
    Kim HJ; Jeon HK; Lee JK; Sung CO; Do IG; Choi CH; Kim TJ; Kim BG; Bae DS; Lee JW
    Anticancer Res; 2013 Apr; 33(4):1555-61. PubMed ID: 23564797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomics-based identification of two novel direct targets of hypoxia-inducible factor-1 and their potential roles in migration/invasion of cancer cells.
    Liao SH; Zhao XY; Han YH; Zhang J; Wang LS; Xia L; Zhao KW; Zheng Y; Guo M; Chen GQ
    Proteomics; 2009 Aug; 9(15):3901-12. PubMed ID: 19637235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of metastasis-associated in colon cancer 1 inhibition by small hairpin RNA on ovarian carcinoma OVCAR-3 cells.
    Zhang R; Shi H; Chen Z; Wu Q; Ren F; Huang H
    J Exp Clin Cancer Res; 2011 Sep; 30(1):83. PubMed ID: 21923915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.